Navigation Links
NSAIDs In First trimester Linked To Congenital Anomalies In Babies

The use of NSAID by women in their first trimester could be associated with cardiac abnormalities in babies. //

Non-steroidal anti-inflammatory drugs, NSAIDs, Cardiac septal defects, Journal Birth Defects Research Part B, Trimester, Pregnancy, Case control, Congenital abnormality, Diabetes

Women who take non-steroidal anti-inflammatory drugs (NSAIDs) early in their pregnancies may be more likely to give birth to babies with congenital defects.

The findings of a new case controlled study has been published in the August issue of the journal Birth Defects Research Part B, which is published by John Wiley & Sons, states that congenital birth defects especially cardiac septal defects, could be associated with the use of NSAID by women in their first trimester. It was reported that article is also available online via Wiley Interscience www.interscience.wiley.com/
journal/bdrb.

Many pregnant women get prescriptions for NSAIDs during their first trimester, and even more--up to 15 percent--take over-the-counter versions of these drugs. Previous studies have shown that taking NSAIDs toward the end of a pregnancy can cause certain circulatory problems--premature closure of the ductus arteriosus and patent ductus arteriosus, but the risks related to early-pregnancy ingestion are less well defined.

To better understand the relationship between first trimester use of NSAIDs and congenital birth defects, researchers led by Anick Berard, Ph.D. of St. Justine Hospital in Montreal, conducted a population-based case-control study. They gathered information from three administrative databases in Quebec and included 36,387 pregnant women in their study. They determined which women had filled prescriptions for NSAIDs during their first trimester and which had babies diagnosed with a congenital abnormality in the first year of life. Based on information from previous studies, the primary outcome of interest was cardiac septa l closure and related abnormalities.

For each infant diagnosed with a congenital abnormality, the researchers matched up to ten controls by date of conception and maternal age, region of residence, and diabetes status. They performed statistical analyses to uncover any associations between the congenital abnormalities and the mother's use of NSAIDs during the first trimester.

Among the 1056 women who filled a prescription for NSAIDs early in their pregnancy, 8.8 percent had babies with congenital anomalies. Of the 35,331 women who did not fill prescriptions for NSAIDs, 7 percent had congenital anomalies. The difference was more pronounced for cardiac septal abnormalities. Furthermore, the proportion of infants with multiple congenital anomalies among mothers who filled an NSAID prescription in the first trimester and those who did not was 16.1 percent vs. 14.2 percent respectively.

"Our analysis of data from the Medication and Pregnancy registry suggests that women who fill prescriptions for NSAIDs in the first trimester of pregnancy may be at greater risk of having children with congenital anomalies, particularly those related to cardiac septal closure," the authors conclude. "This is in accordance with previous findings, but needs to be replicated in other study populations."

(Source: EurekAlert)
'"/>




Related medicine news :

1. The Effectiveness Of NSAIDs Evaluated
2. Study Explains How NSAIDs Halt Cancer Growth
3. Aspirin Or NSAIDs Will not Prevent Colorectal Cancer
4. First Vaccine Designed for Africa Cleared for Testing in Humans
5. Ajanta Launches Worlds First Once-A-Day Nimesulide Oral Formulation
6. First human clone is near
7. First Artificial Heart patient has Major setback
8. First head-to-head trials of once weekly Fosamax and Actonel therapies
9. WHO Declares Vietnam First Country to Control SARS
10. Russia Reports First SARS Case
11. Hope for First New Melanoma Treatment in Decades
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/23/2017)... ... ... March is National Kidney Month – the perfect time to pause and thank ... Every day, two kidneys filter about 120 to 150 quarts of blood. Put another ... regulating fluid levels and blood pressure, supporting bone health and promoting red blood cell ...
(Date:3/23/2017)... ... March 23, 2017 , ... The ... from the NCQA. The accreditation covers StayWell’s asthma, coronary artery disease, congestive heart ... granted to organizations that have excellent programs for the delivery and improvement of ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... program owned and organized by HMP Communications Holdings, LLC, today announced that ... within its nationwide network of wound centers interested in becoming Certified Wound Specialist ...
(Date:3/23/2017)... , ... March 23, 2017 , ... ... families and businesses of the greater Fort Collins area, has unveiled a collaboration ... ongoing community involvement program. Donations to this worthy cause may now be made ...
(Date:3/23/2017)... ... ... After raising more than $1.135 million ($1,479,231 AUD) from nearly 20,000 backers ... crowdfunding history, has established a U.S. Headquarters in New York City, FaceCradle USA, LLC, ... excited to be operating on U.S. shores, where most of our initial crowdfunding backers ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... YORK , March 23, 2017 ... (NASDAQ: MYL), Allergan PLC (NYSE: AGN), Horizon Pharma PLC (NASDAQ: ... These Generic Drugs stocks are part of the Healthcare sector, ... 22 nd , 2017, with the NYSE Health Care Index ... companies in the S&P 500 also were up nearly 0.1% ...
(Date:3/23/2017)... Global Colposcope Market by Manufacturers, Countries, Type and Application, Forecast ... in North America , Europe ... , Middle East and ... regions, type and application. ... Browse 190 Tables and Figures, 19 Major Company Profiles, spread ...
(Date:3/23/2017)... 23, 2017 During the ... Brussels , My UV Patch, La ... habits into life-saving ones, was awarded the Diamond ... in 2016, the "Nudging for Good" Award aims ... desirable for people to change behaviour and adopt ...
Breaking Medicine Technology: